BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10

BRMS1L (breast cancer metastasis suppressor 1 like, BRMS1-like) is a component of Sin3A-histone deacetylase (HDAC) co-repressor complex that suppresses target gene transcription. Here we show that reduced BRMS1L in breast cancer tissues is associated with metastasis and poor patient survival. Functionally, BRMS1L inhibits breast cancer cells migration and invasion by inhibiting epithelial-mesenchymal transition. These effects are mediated by epigenetic silencing of FZD10, a receptor for Wnt signalling, through HDAC1 recruitment and histone H3K9 deacetylation at the promoter. Consequently, BRMS1L-induced FZD10 silencing inhibits aberrant activation of WNT3-FZD10-β-catenin signalling. Furthermore, BRMS1L is a target of miR-106b and miR-106b upregulation leads to BRMS1L reduction in breast cancer cells. RNA interference-mediated silencing of BRMS1L expression promotes metastasis of breast cancer xenografts in immunocompromised mice, whereas ectopic BRMS1L expression inhibits metastasis. Therefore, BRMS1L provides an epigenetic regulation of Wnt signalling in breast cancer cells and acts as a breast cancer metastasis suppressor.

[1]  Yusuke Nakamura,et al.  Inverse correlation of the up‐regulation of FZD10 expression and the activation of β‐catenin in synchronous colorectal tumors , 2009, Cancer science.

[2]  M. Boutros,et al.  The Sin3a repressor complex is a master regulator of STAT transcriptional activity , 2012, Proceedings of the National Academy of Sciences.

[3]  Kedar S Vaidya,et al.  Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells. , 2009, Cancer letters.

[4]  K. Broman,et al.  Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1. , 2001, Cancer research.

[5]  T. Smyrk,et al.  Differential coupling of KLF10 to Sin3-HDAC and PCAF regulates the inducibility of the FOXP3 gene. , 2014, American journal of physiology. Regulatory, integrative and comparative physiology.

[6]  S. Fuqua,et al.  Resveratrol, through NF‐Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor α gene expression via p38MAPK/CK2 signaling in human breast cancer cells , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  P. Paul-Gilloteaux,et al.  ATAT1/MEC-17 acetyltransferase and HDAC6 deacetylase control a balance of acetylation of alpha-tubulin and cortactin and regulate MT1-MMP trafficking and breast tumor cell invasion. , 2012, European journal of cell biology.

[8]  J. Dannenberg,et al.  Sin3a-associated Hdac1 and Hdac2 are essential for hematopoietic stem cell homeostasis and contribute differentially to hematopoiesis , 2014, Haematologica.

[9]  Xun Zhu,et al.  MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis. , 2013, The Journal of clinical investigation.

[10]  D. Welch,et al.  Unraveling the enigmatic complexities of BRMS1‐mediated metastasis suppression , 2011, FEBS letters.

[11]  Zhenyu Zhu,et al.  Effect of BRMS1 on Tumorigenicity and Metastasis of Human Rectal Cancer , 2014, Cell Biochemistry and Biophysics.

[12]  M. Katoh,et al.  Frizzled-10, up-regulated in primary colorectal cancer, is a positive regulator of the WNT - beta-catenin - TCF signaling pathway. , 2002, International journal of molecular medicine.

[13]  K. Friedrichs,et al.  Overexpression of p53 and prognosis in breast cancer , 1993, Cancer.

[14]  M. Hirai,et al.  Molecular cloning of Frizzled-10, a novel member of the Frizzled gene family. , 1999, Biochemical and biophysical research communications.

[15]  J. Reis-Filho,et al.  β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation , 2011, Modern Pathology.

[16]  H. Kirikoshi,et al.  Expression profiles of 10 members of Frizzled gene family in human gastric cancer. , 2001, International journal of oncology.

[17]  L. Chin,et al.  Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression , 1997, nature.

[18]  Marc Ladanyi,et al.  WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis , 2009, Cell.

[19]  Kedar S Vaidya,et al.  Breast Cancer Metastasis Suppressor-1 Differentially Modulates Growth Factor Signaling* , 2008, Journal of Biological Chemistry.

[20]  H. Friess,et al.  Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer , 2011, Gut.

[21]  J. Peterse,et al.  Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.

[22]  C. Gong,et al.  MiR-106b expression determines the proliferation paradox of TGF-β in breast cancer cells , 2013, Oncogene.

[23]  G. Casey,et al.  BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-κB binding site of the uPA promoter , 2009, Clinical & Experimental Metastasis.

[24]  W. Birchmeier,et al.  Wnt signaling in stem and cancer stem cells. , 2013, Current opinion in cell biology.

[25]  G. Casey,et al.  Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1 , 2008, International journal of cancer.

[26]  Yusuke Nakamura,et al.  Therapeutic potential of antibodies against FZD10, a cell-surface protein, for synovial sarcomas , 2005, Oncogene.

[27]  D. Welch,et al.  Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. , 2000, Cancer research.

[28]  Jungsuk An,et al.  Epithelial–mesenchymal transition in breast cancer correlates with high histological grade and triple‐negative phenotype , 2012, Histopathology.

[29]  Ying Sun,et al.  Low BRMS1 expression promotes nasopharyngeal carcinoma metastasis in vitro and in vivo and is associated with poor patient survival , 2012, BMC Cancer.

[30]  P. Munster,et al.  Histone Deacetylase Regulation of ATM-Mediated DNA Damage Signaling , 2013, Molecular Cancer Therapeutics.

[31]  N. Negre,et al.  Sin3a acts through a multi-gene module to regulate invasion in Drosophila and human tumors , 2013, Oncogene.

[32]  Hongyun Wang,et al.  ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer. , 2013, The Journal of clinical investigation.

[33]  D. Welch,et al.  Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer , 2014, British Journal of Cancer.

[34]  Xueli Bao,et al.  MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma , 2011, Journal of experimental & clinical cancer research : CR.

[35]  M. Martinka,et al.  Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis , 2011, Oncogene.

[36]  M. Loda,et al.  Identification of the miR-106b~25 MicroRNA Cluster as a Proto-Oncogenic PTEN-Targeting Intron That Cooperates with Its Host Gene MCM7 in Transformation , 2010, Science Signaling.

[37]  Charles M Perou,et al.  A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. , 2009, Cancer research.

[38]  X. Zhi,et al.  Wnt/beta-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma by increasing hif-1alpha activity and decreasing hypoxia-associated cell death , 2012 .

[39]  R. DePinho,et al.  mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival. , 2005, Genes & development.

[40]  J. Qin,et al.  Identification of a novel BRMS1-homologue protein p40 as a component of the mSin3A/p33(ING1b)/HDAC1 deacetylase complex. , 2004, Biochemical and biophysical research communications.

[41]  C. Plass,et al.  Genome-wide epigenetic regulation of miRNAs in cancer. , 2013, Cancer research.

[42]  Alykhan S. Nagji,et al.  BRMS1 suppresses lung cancer metastases through an E3 ligase function on histone acetyltransferase p300. , 2013, Cancer research.

[43]  M. Dawson,et al.  Cancer Epigenetics: From Mechanism to Therapy , 2012, Cell.

[44]  Kedar S Vaidya,et al.  BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process. , 2008, The American journal of pathology.

[45]  G. Casey,et al.  Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-κB activation , 2007, Molecular Cancer.

[46]  Hans Clevers,et al.  Wnt/β-Catenin Signaling and Disease , 2012, Cell.

[47]  Dongquan Chen,et al.  Breast cancer metastasis suppressor 1 coordinately regulates metastasis‐associated microRNA expression , 2009, International journal of cancer.

[48]  Xiaoqi Liu,et al.  Breast cancer metastasis suppressor 1 inhibits SDF-1alpha-induced migration of non-small cell lung cancer by decreasing CXCR4 expression. , 2008, Cancer letters.

[49]  H. Egami,et al.  Immunohistochemical expression of the c-kit proto-oncogene product in human malignant and non-malignant breast tissues. , 1996, British Journal of Cancer.

[50]  H. Ford,et al.  The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer , 2012, Oncogene.

[51]  Qi Zhang,et al.  Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling. , 2013, Carcinogenesis.

[52]  Kedar S Vaidya,et al.  Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. , 2009, Cancer research.

[53]  M. Mottolese,et al.  ATM kinase activity modulates ITCH E3-ubiquitin ligase activity , 2013, Oncogene.

[54]  Yusuke Nakamura,et al.  Activation of the non-canonical Dvl–Rac1–JNK pathway by Frizzled homologue 10 in human synovial sarcoma , 2009, Oncogene.

[55]  Kedar S Vaidya,et al.  BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation , 2008, Clinical & Experimental Metastasis.